Organon Q3 Adjusted EPS $0.87 Misses $1.07 Estimate, Sales $1.52B Miss $1.58B Estimate
Portfolio Pulse from Benzinga Newsdesk
Organon (NYSE:OGN) reported Q3 earnings of $0.87 per share, missing the analyst consensus estimate of $1.07 by 18.69%. This is a 34.09% decrease from the same period last year. The company also reported quarterly sales of $1.52 billion, missing the analyst consensus estimate of $1.58 billion by 3.86%. This is a 1.17% decrease from the same period last year.
November 02, 2023 | 11:32 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Organon's Q3 earnings and sales missed estimates, with a significant YoY decrease. This could negatively impact the company's stock price.
Organon's earnings and sales for Q3 have both missed estimates, and have decreased significantly compared to the same period last year. This could lead to a decrease in investor confidence and a potential drop in the company's stock price.
CONFIDENCE 90
IMPORTANCE 100
RELEVANCE 100